Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain

Published:2018-01-26 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Terracciano Stefania,Russo Alessandra,Chini Maria G.,Vaccaro Maria C.,Potenza Marianna,Vassallo Antonio,Riccio Raffaele,Bifulco Giuseppe,Bruno Ines

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14902-y.pdf

Reference54 articles.

1. Jego, G., Hazoume, A., Seigneuric, R. & Garrido, C. Targeting heat shock proteins in cancer. Cancer Lett. 332, 275–285 (2013).

2. Whitesell, L. & Lindquist, S. L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5, 761–772 (2005).

3. Wang, X., Chen, M., Zhou, J. & Zhang, X. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int. J. Oncol. 45, 18–30 (2014).

4. Taldone, T., Ochiana, S. O., Patel, P. D. & Chiosis, G. Selective targeting of the stress chaperome as a therapeutic strategy. Trends Pharmacol. Sci. 35, 592–603 (2014).

5. Sidera, K. & Patsavoudi, E. Extracellular HSP90: conquering the cell surface. Cell cycle 7, 1564–1568 (2008).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency;Biomedicine & Pharmacotherapy;2024-08

2. Pd‐Catalyzed Coupling of Bromo‐N‐ (β‐glucopyranosyl)quinolin‐2‐ones with Amides: Synthesis of N‐glucosyl‐6BrCaQ Conjugates with Potent Anticancer Activity;ChemMedChem;2024-06-15

3. Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer;iScience;2023-12

4. Diptoindonesin G, a new Hsp90 drug;Journal of Biological Chemistry;2023-01

5. Recent advances toward the development of Hsp90 C-terminal inhibitors;Bioorganic & Medicinal Chemistry Letters;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3